Although activation of RAGE with its ligands, AGEs has been known to play a crucial role in the development and progression of atherosclerotic cardiovascular disease, it remains unclear whether SMTP-44D could inhibit experimental atherosclerosis by suppressing the AGEs–RAGE axis. This evidence concerns the gene AGER and atherosclerosis.